Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors

Summary

This study is a multi-center, open label, dose escalation/dose expansion phase I clinical trial aimed at evaluating the safety, tolerability, PK characteristics, and preliminary efficacy characteristics of QLS1304 monotherapy in patients with advanced malignant solid tumors. This study was divided into two stages: dose escalation and dose expansion.

Timeline

Start

2025-03-06

Primary completion

2026-11

Completion

2027-12

Drugs

Indications